EP1768722A1 - Canules et systeme presentant une resistance reduite a l'ecoulement - Google Patents
Canules et systeme presentant une resistance reduite a l'ecoulementInfo
- Publication number
- EP1768722A1 EP1768722A1 EP05757823A EP05757823A EP1768722A1 EP 1768722 A1 EP1768722 A1 EP 1768722A1 EP 05757823 A EP05757823 A EP 05757823A EP 05757823 A EP05757823 A EP 05757823A EP 1768722 A1 EP1768722 A1 EP 1768722A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- cannula
- lumen
- blood
- multilumen
- distal end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000002829 reductive effect Effects 0.000 title description 21
- 210000004369 blood Anatomy 0.000 claims abstract description 180
- 239000008280 blood Substances 0.000 claims abstract description 180
- 230000007704 transition Effects 0.000 claims description 168
- 230000017531 blood circulation Effects 0.000 claims description 115
- 210000004204 blood vessel Anatomy 0.000 claims description 110
- 238000003780 insertion Methods 0.000 claims description 69
- 230000037431 insertion Effects 0.000 claims description 69
- 239000012530 fluid Substances 0.000 claims description 36
- 230000001603 reducing effect Effects 0.000 claims description 23
- 238000004891 communication Methods 0.000 claims description 12
- 238000007599 discharging Methods 0.000 claims description 10
- 230000003116 impacting effect Effects 0.000 claims description 3
- 230000000916 dilatatory effect Effects 0.000 claims 1
- 210000005166 vasculature Anatomy 0.000 abstract description 66
- 230000002792 vascular Effects 0.000 description 51
- 238000000034 method Methods 0.000 description 44
- 238000005086 pumping Methods 0.000 description 37
- 210000000709 aorta Anatomy 0.000 description 31
- 230000008901 benefit Effects 0.000 description 29
- 230000002169 extracardiac Effects 0.000 description 25
- 210000001105 femoral artery Anatomy 0.000 description 22
- 230000001965 increasing effect Effects 0.000 description 20
- 210000002376 aorta thoracic Anatomy 0.000 description 19
- 210000001367 artery Anatomy 0.000 description 19
- 230000002093 peripheral effect Effects 0.000 description 19
- 239000000463 material Substances 0.000 description 16
- 210000003270 subclavian artery Anatomy 0.000 description 16
- 230000003872 anastomosis Effects 0.000 description 14
- 230000006378 damage Effects 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 210000005259 peripheral blood Anatomy 0.000 description 10
- 239000011886 peripheral blood Substances 0.000 description 10
- 238000007789 sealing Methods 0.000 description 10
- 230000000747 cardiac effect Effects 0.000 description 9
- 230000009467 reduction Effects 0.000 description 8
- 210000003462 vein Anatomy 0.000 description 8
- 230000003993 interaction Effects 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 230000000541 pulsatile effect Effects 0.000 description 7
- 239000013589 supplement Substances 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 206010019280 Heart failures Diseases 0.000 description 6
- 210000001765 aortic valve Anatomy 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 210000002254 renal artery Anatomy 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 206010007559 Cardiac failure congestive Diseases 0.000 description 5
- 230000000712 assembly Effects 0.000 description 5
- 238000000429 assembly Methods 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 210000000601 blood cell Anatomy 0.000 description 5
- 230000008081 blood perfusion Effects 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 210000003975 mesenteric artery Anatomy 0.000 description 5
- 230000001360 synchronised effect Effects 0.000 description 5
- 230000008733 trauma Effects 0.000 description 5
- 210000004191 axillary artery Anatomy 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 210000003191 femoral vein Anatomy 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- 230000002861 ventricular Effects 0.000 description 4
- 206010018910 Haemolysis Diseases 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 229920002614 Polyether block amide Polymers 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 210000001715 carotid artery Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 230000002939 deleterious effect Effects 0.000 description 3
- 230000008588 hemolysis Effects 0.000 description 3
- 201000002818 limb ischemia Diseases 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000009469 supplementation Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 210000004013 groin Anatomy 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 210000003090 iliac artery Anatomy 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002324 minimally invasive surgery Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 230000036316 preload Effects 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000000153 supplemental effect Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 229920004934 Dacron® Polymers 0.000 description 1
- 229920000544 Gore-Tex Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- -1 e.g. Polymers 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004249 mesenteric artery inferior Anatomy 0.000 description 1
- 210000001363 mesenteric artery superior Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002644 neurohormonal effect Effects 0.000 description 1
- 230000001453 nonthrombogenic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001706 oxygenating effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000008320 venous blood flow Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M25/003—Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the distal part of the catheter, e.g. filters, plugs or valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
- A61M1/3659—Cannulae pertaining to extracorporeal circulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M25/0032—Multi-lumen catheters with stationary elements characterized by at least one unconventionally shaped lumen, e.g. polygons, ellipsoids, wedges or shapes comprising concave and convex parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M2025/0073—Tip designed for influencing the flow or the flow velocity of the fluid, e.g. inserts for twisted or vortex flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
- A61M2027/004—Implant devices for drainage of body fluids from one part of the body to another with at least a part of the circuit outside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3507—Communication with implanted devices, e.g. external control
- A61M2205/3523—Communication with implanted devices, e.g. external control using telemetric means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3561—Range local, e.g. within room or hospital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/0071—Multiple separate lumens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
- A61M25/0075—Valve means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14276—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
Definitions
- a cannula system includes a multilumen cannula and a dilator.
- the multilumen cannula includes a first elongate body and a second elongate body.
- the first elongate body has a proximal portion, a distal portion, and a first lumen that extends through the first elongate body.
- the first lumen is configured to reduce resistance to flow therethrough.
- a percutaneous cannula comprises a main cannula portion, a discharge opening, and a transition portion.
- the transition portion extends distally from the main cannula portion and has a lumen therethrough.
- the transition portion is configured to engage an adjacent wall of a blood vessel to space the discharge opening of the cannula from the adjacent wall of the blood vessel. Blood discharge from a blood flow lumen through the discharge opening that directly impacts upon the blood vessel wall is substantially reduced by this arrangement.
- a percutaneous cannula comprises a main cannula portion and a transition portion.
- the transition portion has a helical shape and includes a plurality of axially spaced discharge apertures.
- one or more of the conduits could be connected to veins, i the arrangement of Figure 3, the inflow conduit 150 A is connected to the left femoral artery 26 while the inflow conduit 150B is connected to the left femoral vein 30.
- the outflow conduit 152A is connected to the left subclavian artery 24 while the outflow conduit 152B is connected to the left carotid artery 22.
- at least one of the conduits 150A, 150B, 152A, and 152B is coupled with a corresponding vessel via a cannula.
- the inflow conduit 150B is coupled with the left femoral vein 30 via a cannula 160.
- the outflow port 492 may be situated within, for example, a mesenteric artery 494 such that blood flow results from the left femoral artery 26 to the mesenteric artery 494.
- the blood could discharge, for example, directly into the descending aorta proximate an arterial branch, such as the renal arteries, the left subclavian artery, or directly into the peripheral mesenteric artery 494, as illustrated in Figure 11.
- the multilumen cannula 484 preferably is made of material sufficiently flexible and resilient to permit the patient 12 to comfortably move about while the cannula 484 is indwelling in the patient's blood vessels without causing any vascular trauma.
- the intrasvascular extracardiac system 642 may further comprise inflow and/or outflow conduits or cannulae (not shown) fluidly connected to the pumping means 644, e.g., to the inlet and outlet of pump 646.
- Any suitable conduit or cannula can be employed.
- a cannula having a redirecting tip portion such as the any of the cannulae of Figures 17A - 32B, could be coupled with an intrasvascular extracardiac system.
- r is the radius of the vessel being assessed
- ⁇ is the frequency of the patient's heartbeat
- ⁇ the viscosity of the fluid.
- a Womersley number of at least 6 is preferred, although a value as low as 5 would be acceptable.
- the cannula 702 is defined by a proximal end 708, a distal end 710, and a blood-flow lumen 712 extending substantially entirely therethrough.
- the transition portion 706 may be a discrete component connected in a suitable fashion to the main cannula portion 704.
- the transition portion 706 is configured to re-direct blood-flow in a manner discussed below.
- the main cannula portion 704 is generally cylindrical, extending along a longitudinal axis Li from the proximal end 708 toward the transition portion 706.
- the cannula 702 could be configured to have a plurality of lumens therethrough that can be employed to considerable advantage in connection with heart assist systems adapted for single-site application.
- the guide-member 724 is a standard guidewire used in percutaneous procedures.
- the straightener 726 is a stiff member that reduces the profile of the transition portion 706, as discussed above, hi one embodiment, the straightener 726 is a stiff cylindrical rod with a lumen extending therethrough. The lumen in the straightener 726 is sized to receive the guide-member 724. In the illustrated embodiment, the outer diameter of the straightener 726 is sized to be received by the lumen 712 of the percutaneous cannula 702. The straightener 726 is stiffer than the percutaneous cannula 702.
- the blood flow exiting the lumen 754 is generally away from a wall 764 of the vessel V which is nearest to the transition portion 744.
- the cannula 740 may be applied so that the blood flow exiting the lumen 754 also is generally in the same direction of the flow of blood in the vessel V.
- a system 770 for deploying the cannula 740 may be provided.
- the system 770 is similar to the system 722.
- the system 770 includes the percutaneous cannula 740, a guide-member 772, and a straightener 774.
- the cannula 830 is configured to convey blood between two or more vessels. In other embodiments and applications, the cannula 830 is configured to convey blood from one area of a vessel to another area of the vessel. An arrow 838 illustrates the blood- flow within the lumen 836, where the cannula 830 is applied as an outflow cannula. [0193] In one embodiment, the tip portion 834 includes a plurality of apertures 840 to direct blood flow between the lumen 836 and the vessel V in an advantageous manner, e.g., to minimize or eliminate any potentially harmful interactions between the cannula 830 and the vessel V.
- the cannula 850 can also be applied to convey blood from one portion of a vessel, into the lumen 856, and out of the lumen 856 into another part of a vessel. As with the other cannulae described herein, the cannula 850 can be configured as either a single or as a multilumen cannula. [0196]
- the tip portion 854 includes a curved surface 862 positioned distal of the blood-flow lumen 856.
- the funnel portion 868 directs substantially all of the blood that is flowing in the lumen 856 toward the surface 862 of the tip portion 854, which redirects the blood-flow as discussed above.
- the cannula 850 redirects blood-flow to prevent the blood-flow exiting the distal end 860 from immediately discharging against a wall of the vessel. Thus the cannula 850 reduces the likelihood that the blood-flow will have an adverse effect on the vessel in which the cannula 850 resides or on the vasculature in general.
- the cannula 850 is provided with means for sealing the guide-member lumen 858.
- the sealing means can be any suitable structure.
- One embodiment provides a mechanical valve 870.
- the cannula 902 may be configured as a single or a multiple lumen cannula, as discussed above.
- the tip portion 906 like the tip portions of the other cannulae described herein, may be made of a similar material or any other suitable material.
- the tip portion 906 is configured to direct blood-flow in a direction generally opposite of the direction of flow through the lumen 910.
- the average direction of blood flow out of the tip portion 906 is along a line that forms about a one-hundred sixty-five degree angle with respect to the longitudinal axis (not shown) of the lumen 910.
- the tip portion 906 has a plurality of lateral openings 912 located near the distal end 908 and a redirecting member 914.
- the thickness of the redirecting member 914 can be reduced to enable it to expand an equivalent amount as a fully covering member at a lower pressure.
- the hardness of the redirecting member 914 can be reduced to enable the member 914 to expand an equivalent amount at a lower pressure.
- the cannula 902 has a binary construction that provides a redirecting member 914 that has two discrete pre-defined configurations. This construction is analogous to that of an umbrella, which may be actuated from a collapsed, low profile configuration to a pre-determined, expanded operational configuration.
- the redirecting member 914 has a first, pre-defined configuration for delivery, e.g., a collapsed configuration, and a second, pre-defined configuration for operation.
- the surface 920 and / or the redirecting member 914 direct the blood in a direction generally opposite of the direction of blood-flow in the lumen 910.
- the cannula 902 may advantageously prevent blood-flow exiting the tip portion 906 from immediately discharging against a wall of the vessel. The likelihood of any deleterious effect on the vessel in which the cannula 902 is applied or other harm to the vasculature due to the operation of the cannula 902 is thereby reduced.
- the tip portion 906 includes a tapered portion 922.
- the S-shaped configuration provides a first lateral extending portion 950 and a second laterally extending portion 952.
- the first laterally extending portion 950 may extend laterally until it engages a wall W 1 of the vessel V.
- the lateral extent of the first laterally extending portion 950 is preferably sufficient to cause the distal end of the main caimula portion 944 to be moved adjacent to, or even to engage, the opposite wall W 2 of the vessel V.
- the lateral extent of the second laterally extending portion 952 is preferably sufficient to position the distal end of the transition portion 946 about in the center of the vessel V.
- the cannula 970 is configured so that it can be inserted into the vasculature at another non-primary artery, e.g., an axillary artery, and advanced until the first distal end 990 is at, adjacent to, or within any of the foregoing arteries (e.g., an iliac or femoral artery) or any other of the vessels or classes of vessels described herein.
- the cannula 970 is configured so that the length of the first lumen 982 from the proximal end 986 to the first distal end 990 is between about 60 and about 90 cm.
- the cannula 1666 In order to minimize the flow resistance in the cannula 1666, it is desirable to design the cannula so that the distal portion 1692 comprises as much of the total length of the cannula 1666 as is possible, given other constraints on the cannula 1666. Thus, the length of the proximal portion 1682, and therefore the length of the second lumen 1674, will be minimized as much as is possible.
- the cross- sectional shape of the lumen 1734 preferably is circular at points within the proximal portion 1746, the transition portion 1748, and the distal portion 1754.
- the cross-sectional shape of the second lumen 1734 is circular along the entire length of the first elongate portion 1732.
- the inner cross-sectional size of the first lumen 1734 expands compared to the inner-cross-sectional size of the first lumen 1734 in the proximal portion 1746 of the multilumen cannula 1730 distal a location corresponding to the second distal end 1742.
- the length of the transition portion 1748 may be any suitable length, e.g., one that provides gradual increase distally to prevent abrupt changes in flow direction of the blood. In one embodiment, the length of the transition portion 1748 is about one- half inch. In one embodiment, the length of the transition portion 1748 is about one inch or less. In another embodiment, the length of the transition portion 1748 is about one inch.
- a cannula assembly includes a dilator that is insertable through the distally increasing lumen and that can be configured after insertion into the lumen to reduce trauma to surrounding tissue during insertion of the cannula assembly.
- a dilator that is insertable through the distally increasing lumen and that can be configured after insertion into the lumen to reduce trauma to surrounding tissue during insertion of the cannula assembly.
- the expandable member 1780 may be inflated with saline solution or any other suitable liquid or gas.
- the dilator 1778 may also include a valve 1786 as shown in Figure 34 in fluid communication with the inflation lumen.
- the valve 1786 can take any suitable form. In one embodiment, the valve 1786 can be actuated to a closed position after inflation fluid from the inflation means inflates the expandable member 1780 and can be actuated to an open position to allow the inflation fluid in the expandable member 1780 to escape from the expandable member 1780.
- This arrangement will facilitate moving the first elongate portion 1762 to the proper position while the cannula 1760 is inserted into a vessel 1792 of the patient and therefore not visible.
- the second elongate portion 1764 may be translated, rather than the first elongate portion 1762.
- the cannula 1760 must be inserted into the vessel 1792 so that the entire transition portion 1774 is located within the vessel 1778.
- care should be taken that the second distal end 1770 is not moved proximal the cannulation site 1794.
- the pump 1798 may be any suitable pump, e.g., any of those discussed above.
- the pump 1798 may be one that is configured to pump blood at subcardiac rates.
- the pump 1798 may also be implanted subcutaneously, e.g., just beneath the skin or within the vasculature, as discussed above.
- Arrow 1808 indicates blood flow that is conveyed from the pump 1798 to the first proximal end 1768 of the first elongate body 1762 through a conduit 1810 or other suitable conveyance. Blood flow enters the first lumen at the first proximal end 1768 and flows distally therein, as indicated by arrow 1812 to the transition portion 1774.
- the pump is to be implanted into the patient, or the patient is desired to be ambulatory, it is desirable to minimize both the size and power consumption of the pump.
- power consumption can be reduced by reducing the flow resistance in these cannulae.
- the flow resistance of a cannula can be reduced by decreasing the overall length of the cannula, decreasing the viscosity of the fluid, or increasing the cross-sectional size of the cannula lumen or interior, as discussed above.
- the total cross-sectional size of the cannula is restricted by the size of the blood vessel into which the cannula is inserted.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Physics & Mathematics (AREA)
- Geometry (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- External Artificial Organs (AREA)
Abstract
L'invention concerne une canule multilumière (1700) destinée à l'échange sanguin s'effectuant à l'intérieur de la vasculature d'un patient. La canule (1700) de l'invention comprend une première partie allongée (1702) définissant une première lumière (1704) et une seconde partie allongée (1706) définissant une seconde lumière (1708). La première partie allongée (1702) s'étend entre une première extrémité distale (1710) et une extrémité proximale (1714). La seconde partie allongée (1706) s'étend entre une seconde extrémité distale (1712) et l'extrémité proximale (1714). Au moins la première partie allongée (1702) ou la seconde partie allongée (1706) est configurée pour réduire la résistance à l'écoulement, à travers la canule.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/865,045 US20050277804A1 (en) | 2004-06-10 | 2004-06-10 | System including a cannula having reduced flow resistance |
| US10/866,535 US7445592B2 (en) | 2004-06-10 | 2004-06-10 | Cannulae having reduced flow resistance |
| US10/866,649 US20050277870A1 (en) | 2004-06-10 | 2004-06-10 | Cannula having reduced flow resistance |
| PCT/US2005/020663 WO2005123158A1 (fr) | 2004-06-10 | 2005-06-10 | Canules et systeme presentant une resistance reduite a l'ecoulement |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1768722A1 true EP1768722A1 (fr) | 2007-04-04 |
Family
ID=34971945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP05757823A Withdrawn EP1768722A1 (fr) | 2004-06-10 | 2005-06-10 | Canules et systeme presentant une resistance reduite a l'ecoulement |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP1768722A1 (fr) |
| WO (1) | WO2005123158A1 (fr) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7393181B2 (en) | 2004-09-17 | 2008-07-01 | The Penn State Research Foundation | Expandable impeller pump |
| CA2646277C (fr) | 2006-03-23 | 2016-01-12 | The Penn State Research Foundation | Dispositif d'assistance cardiaque avec une pompe a impulseur extensible |
| JP5757537B2 (ja) * | 2009-06-04 | 2015-07-29 | カーディオガード メディカル リミテッド | 動脈装置、動脈系、および方法 |
| WO2012094641A2 (fr) | 2011-01-06 | 2012-07-12 | Thoratec Corporation | Pompe cardiaque percutanée |
| US9327067B2 (en) | 2012-05-14 | 2016-05-03 | Thoratec Corporation | Impeller for catheter pump |
| US9872947B2 (en) | 2012-05-14 | 2018-01-23 | Tc1 Llc | Sheath system for catheter pump |
| GB2504176A (en) | 2012-05-14 | 2014-01-22 | Thoratec Corp | Collapsible impeller for catheter pump |
| US9446179B2 (en) | 2012-05-14 | 2016-09-20 | Thoratec Corporation | Distal bearing support |
| US8721517B2 (en) | 2012-05-14 | 2014-05-13 | Thoratec Corporation | Impeller for catheter pump |
| DE102013008159A1 (de) | 2012-05-14 | 2013-11-14 | Thoratec Corporation | Mantelsystem für Katheterpumpe |
| EP4186557A1 (fr) | 2012-07-03 | 2023-05-31 | Tc1 Llc | Ensemble motour pour pompe à cathéter |
| US9358329B2 (en) | 2012-07-03 | 2016-06-07 | Thoratec Corporation | Catheter pump |
| US9421311B2 (en) | 2012-07-03 | 2016-08-23 | Thoratec Corporation | Motor assembly for catheter pump |
| US11077294B2 (en) | 2013-03-13 | 2021-08-03 | Tc1 Llc | Sheath assembly for catheter pump |
| EP2968718B1 (fr) | 2013-03-13 | 2021-04-21 | Tc1 Llc | Système de traitement de fluide |
| US11033728B2 (en) | 2013-03-13 | 2021-06-15 | Tc1 Llc | Fluid handling system |
| US9308302B2 (en) | 2013-03-15 | 2016-04-12 | Thoratec Corporation | Catheter pump assembly including a stator |
| WO2014143593A1 (fr) | 2013-03-15 | 2014-09-18 | Thoratec Corporation | Ensemble pompe de cathéter comprenant un stator |
| US9827356B2 (en) | 2014-04-15 | 2017-11-28 | Tc1 Llc | Catheter pump with access ports |
| EP4417244A3 (fr) | 2014-04-15 | 2024-10-16 | Tc1 Llc | Système d'introduction de pompe de cathéter |
| US10029037B2 (en) | 2014-04-15 | 2018-07-24 | Tc1 Llc | Sensors for catheter pumps |
| WO2015160942A1 (fr) | 2014-04-15 | 2015-10-22 | Thoratec Corporation | Pompe de cathéter avec position de moteur excentrée |
| EP3183024B1 (fr) | 2014-08-18 | 2019-09-18 | Tc1 Llc | Eléments de guidage pour une pompe de cathéter percutané |
| US9675738B2 (en) | 2015-01-22 | 2017-06-13 | Tc1 Llc | Attachment mechanisms for motor of catheter pump |
| EP3247420B1 (fr) | 2015-01-22 | 2019-10-02 | Tc1 Llc | Ensemble moteur à masse de rotation réduite pour pompe pour cathéter |
| EP4578485A3 (fr) | 2015-01-22 | 2025-08-13 | Tc1 Llc | Ensemble moteur pour pompe de cathéter |
| US9907890B2 (en) | 2015-04-16 | 2018-03-06 | Tc1 Llc | Catheter pump with positioning brace |
| EP3487549B1 (fr) | 2016-07-21 | 2021-02-24 | Tc1 Llc | Joints fluidiques pour ensemble de moteur de pompe à cathéter |
| EP3808401A1 (fr) | 2016-07-21 | 2021-04-21 | Tc1 Llc | Chambre remplie de gaz pour ensemble moteur de pompe de cathéter |
| JP7462616B2 (ja) * | 2018-09-28 | 2024-04-05 | コーニンクレッカ フィリップス エヌ ヴェ | 体腔から生物学的物質を吸引するためのシステム、デバイス及び方法 |
| WO2021146227A1 (fr) * | 2020-01-14 | 2021-07-22 | Abiomed, Inc. | Pompe sanguine intravasculaire à tuyau de sortie |
| WO2024025499A2 (fr) * | 2022-07-28 | 2024-02-01 | Buharalioglu Yavuz Selim | Système d'accès vasculaire |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU400331A1 (fr) * | 1971-07-06 | 1973-10-01 | ||
| US5616137A (en) * | 1995-02-22 | 1997-04-01 | Minnesota Mining And Manufacturing Company | Low velocity aortic cannula |
| US6053900A (en) * | 1996-02-16 | 2000-04-25 | Brown; Joe E. | Apparatus and method for delivering diagnostic and therapeutic agents intravascularly |
| US5836912A (en) * | 1996-10-21 | 1998-11-17 | Schneider (Usa) Inc. | Catheter having nonlinear flow portion |
| WO1999065546A1 (fr) * | 1998-06-19 | 1999-12-23 | A-Med Systems, Inc. | Appareil et procedes de penetration dans des cavites du corps |
| WO2000012148A2 (fr) * | 1998-08-27 | 2000-03-09 | A-Med Systems Inc. | Appareil de canulation intravasculaire et ses methodes d'utilisation |
| GB9828696D0 (en) * | 1998-12-29 | 1999-02-17 | Houston J G | Blood-flow tubing |
| US7108674B2 (en) * | 2000-08-30 | 2006-09-19 | Radius International Limited Partnership | Catheter |
| US20020188167A1 (en) * | 2001-06-06 | 2002-12-12 | Anthony Viole | Multilumen catheter for minimizing limb ischemia |
-
2005
- 2005-06-10 EP EP05757823A patent/EP1768722A1/fr not_active Withdrawn
- 2005-06-10 WO PCT/US2005/020663 patent/WO2005123158A1/fr not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2005123158A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005123158A1 (fr) | 2005-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1687055B1 (fr) | Cannule presentant une pointe de réorientation | |
| WO2005123158A1 (fr) | Canules et systeme presentant une resistance reduite a l'ecoulement | |
| US7445592B2 (en) | Cannulae having reduced flow resistance | |
| US7125376B2 (en) | Implantable heart assist system and method of applying same | |
| US7591778B2 (en) | Implantable heart assist system and method of applying same | |
| US20060224110A1 (en) | Methods for minimally invasive vascular access | |
| US20050085683A1 (en) | Implantable heart assist system and method of applying same | |
| US20070213690A1 (en) | Blood conduit connector | |
| US20090043241A1 (en) | Quick priming connectors for blood circuit | |
| US20050277804A1 (en) | System including a cannula having reduced flow resistance | |
| US20050131385A1 (en) | Cannulae for selectively enhancing blood flow | |
| US20050277870A1 (en) | Cannula having reduced flow resistance | |
| HK1151483A (en) | Cannulae having a redirecting tip | |
| US20060184199A1 (en) | Apparatus and methods for reducing bleeding from a cannulation site |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20070110 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Effective date: 20090730 |